ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2498

ERAP2 Functional Knockout In Humans Does Not Alter ER Stress Or Evidence Of HLA-B27 Misfolding In Ankylosing Spondylitis

Philip Robinson1, Yang Wang2, Eugene Lau2, Patricia Keith2, Tony Kenna3 and Matthew A. Brown3, 1Human Genetics Group, University of Queensland Diamantina Insititute, Brisbane, Australia, 2Human Genetics Group, University of Queensland Diamantina Institute, Brisbane, Australia, 3University of Queensland Diamantina Institute, Brisbane, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and genetics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

SNPs in ERAP2 are strongly associated with ankylosing spondylitis (AS). One associated SNP is rs2248374 which changes the strength of the exon 10 donor splice site, with the G allele resulting in a truncated protein which is degraded by nonsense-mediated decay, resulting in a complete absence of ERAP2. This allele has a frequency of approximately 0.5 in the European descendent population, therefore 25% of the population (those who are GG homozygous) are natural ERAP2 knockouts. We investigated the effect of this associated variant on HLA class I allele presentation, HLA class I heavy chain presentation, ER stress markers and pro-inflammatory cytokine gene transcription in AS.

Methods:

AS patients and healthy controls with either AA or GG homozygous status for rs2248374 were recruited. Ficoll gradient separated PBMCs were analysed with flow cytometry. Anti-CD14-Pacific Blue, anti-CD19-ECD, anti-HLA-A,B,C-PECy7, anti-V alpha7.2-PE, anti-CD161-PerCy5.5, anti-HC10 and anti-HLA-B27 were used to analyse the PBMCs. Cells were analysed as monocytes, B cells and mucosal associated invariant T (MAIT) cells.  Expression levels of endoplasmic reticulum (ER) stress markers (GRP78 and CHOP) and pro-inflammatory genes (TNF, IL-6, IL-17 and IL-22) were assessed by RT-PCR in unsorted PBMCs, normalised to RPL32 housekeeping gene-expression.

Results:

7 AS cases and 8 controls with GG genotype, and 8 AS cases and 8 controls with the AA genotype (all HLA-B27 positive) were analysed. rtPCR patient numbers were: B27+ERAP2 AA = 8 ; B27+ ERAP2 GG = 12; B27-ERAP2 AA = 16; B27-ERAP2 GG = 15. Comparing rs2248374 AA and GG genotype carriers, there were no significant differences in HLA Class I expression or free HLA Class I heavy chain levels either intracellularly or extracellularly, ER stress as measured by expression of markers GRP78 and CHOP, or pro-inflammatory gene expression.  Also, no difference in ER stress markers or free HLA Class I heavy chain levels was noted between AS cases and healthy controls in any cell type studied.

Conclusion:

The study demonstrates that there are not large differences in surface expression of class I antigens or heavy chains, ER stress or proinflammatory cytokine gene expression between the two genotypes in AS cases. This suggests that ERAP2 loss of function variants which are protective against AS do not operate by effects on ER stress or HLA Class I misfolding.  Further, the absence of a difference between cases and controls in measures of either free HLA Class I heavy chain levels or ER stress markers is not consistent with HLA-B27 operating to cause AS through either misfolding or ER stress induction, at least in the cell types studied.


Disclosure:

P. Robinson,
None;

Y. Wang,
None;

E. Lau,
None;

P. Keith,
None;

T. Kenna,
None;

M. A. Brown,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/erap2-functional-knockout-in-humans-does-not-alter-er-stress-or-evidence-of-hla-b27-misfolding-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology